The FDA approved new therapy for rare disease affecting optic nerve, spinal cord
On Jun. 11, 2020, the FDA approved Viela Bio’s Uplizna (inebilizumab-cdon) injection for intravenous use for the treatment…
On Jun. 11, 2020, the FDA approved Viela Bio’s Uplizna (inebilizumab-cdon) injection for intravenous use for the treatment…
On Jun. 11, 2020, Atossa Therapeutics announced that the manuscript of the results from in vitro testing of…
On Jun. 11, 2020, scientists at the Universities of Oxford, Exeter, Yunnan and Bristol announced thay had discovered…
On Jun. 11, 2020, Sinovac Biotech announced the signing of a clinical development collaboration agreement to advance the…
On Jun. 11, 2020, Emergent BioSolutions announced deployment of its molecule-to-market contract development and manufacturing (CDMO) services to…
On Jun. 11, 2020, AIM ImmunoTech announced that it had filed a provisional patent application for, among other…
On Jun. 11, 2020, Innovation Pharma announced the Company and researchers at a U.S. Regional Biocontainment Laboratory (RBL)…
On Jun. 11, 2020, CHF Solutions announced that it has sold Aquadex SmartFlowル consoles and disposables to a…
On Jun. 11, 2020, Regeneron announced initiation of the first clinical trial of REGN-COV2, its investigational dual antibody…
On Jun. 11, 2020, a new study led by UT Southwestern researchers revealed the structure of the active…
On Jun. 10, 2020, the World Trade Organizationメs (WTO) Appellate Body reported on the dispute brought by Honduras…
On Jun. 10, 2020, the FDA issued an emergency use authorization (EUA) to Illumina for the first COVID-19…
On Jun. 10, 2020, Johnson & Johnson announced that through its Janssen Pharmaceutical subsidiary it has accelerated the…
On Jun. 10, 2020, Catalent announced that it had signed an agreement with Spicona to develop a virus-like…
On Jun. 9, 2020, people with small airways relative to the size of their lungs may have a…
On Jun. 9, 2020, a Scripps research analysis of public datasets on asymptomatic infections, an extraordinary percentage of…
On Jun. 9, 2020, OpGen announced preliminary data from an investigator initiated collaboration with Karolinska Institutet, Stockholm, Sweden,…
On Jun. 9, 2020, Immunic announced receipt of regulatory allowance from the FDA to initiate its phase 2,…
On Jun. 9, 2020, Aegis Sciences announced that it was registered and approved to provide public health reporting…
On Jun. 8, 2020, OraSure Technologies announced that Phosphorus Diagnostics, a leader in diagnostic and bioinformatic solutions for…
On Jun. 8, 2020, Emergency health measures implemented in six major countries have モsignificantly and substantially slowedヤ the…
On Jun. 8, 2020, Innovent Biologics announced a strategic research and development collaboration with Roche covering multiple cell…
On Jun. 8, 2020, Aimmune Therapeutics announced two-year data that suggested long-term efficacy of daily treatment with PALFORZIA…
On Jun. 8, 2020, FibroGen announced the initiation of an open-label, randomized, parallel-arm study investigating the efficacy and…
On Jun. 8, 2020, Eli Lilly announced its partner Junshi Biosciences had dosed the first healthy volunteer in…
On Jun. 5, 2020, early data from a clinical study suggested that blocking the Bruton tyrosine kinase (BTK)…
On Jun. 5, 2020, to jumpstart the Department of Defense’s (DoD) SARS-CoV-2 sequencing efforts, Armed Forces Health Surveillance…
On Jun. 5, 2020, results were published in Science Immunology showed that Calquence (acalabrutinib), a Brutonメs tyrosine kinase…
On Jun. 5, 2020, the UK thelped secure $7.4 billion in funding to support global vaccine supply and…
On Jun. 4, 2020, vaccine manufacturers MSD, GSK, Innovax, Serum Institute of India and Walvax pledged to ramp…